Document is current

Any future updates will be listed below

Targeting of circulating Th17 cells by β-D-mannuronic acid (M2000) as a novel medication in patients with rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1007/s10787-017-0410-8

Published Online: 2017-10-23

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark